Douglas M. Dahl - Concepedia

Author

Douglas M. Dahl

Also Known As

Adam Kibel, Anthony Zietman, D M Dahl, D. Dahl, D. M. Dahl, D.M. Dahl, DOUGLAS M. DAHL, Dahl, Douglas, Dahl, Douglas M, Douglas Dahl

223

Publications

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Sidney Kimmel Comprehensive Cancer Center The University of Texas MD Anderson Cancer Center Duke Cancer Institute

About

Douglas M. Dahl is an author at Massachusetts General Hospital specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	2.9K
2	Health Sciences	9	9	511
3	Engineering	6	6	1.1K
4	Public Health	5	5	561
5	Applied Physiology	1	1	10

Douglas M. Dahl

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance David T. Miyamoto, Yu Zheng, Ben S. Wittner, Science	2015	711
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer Shannon L. Stott, Richard J. Lee, Sunitha Nagrath, Science Translational Medicine Surgical OncologyEngineeringCirculating Tumor CellsCancer BiologyTumor Biology	2010	535
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience Nicholas J. Giacalone, William U. Shipley, R.H. Clayman, European Urology Urological ResearchUrologySurgical OncologyVoiding DysfunctionGenitourinary Cancer	2017	390
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016 Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Journal of the National Comprehensive Cancer Network Preclinical TherapeuticsNccn Guidelines InsightsPopulation Health SciencesGynecology OncologyOncology	2016	341
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, The Lancet Oncology Urological ResearchUrologySurgical OncologyGenitourinary CancerMedicine	2023	223
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses Taghreed Hirz, Shenglin Mei, Hirak Sarkar, Nature Communications EngineeringImmunologyImmunotherapySpatial OmicsTumor Biology	2023	206
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023 Kelvin A. Moses, Preston Sprenkle, Clinton D. Bahler, Journal of the National Comprehensive Cancer Network Nccn Guidelines® InsightsUrologyNegative Biopsy ResultsMedical ImagingGenitourinary Cancer	2023	139
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer David T. Miyamoto, Richard J. Lee, Mark Kalinich, Cancer Discovery	2018	133
A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: A new method for noninvasive lymph node evaluation Mukesh G. Harisinghani, Mansi A. Saksena, Robert W. Ross, Urology NanomedicineEngineeringHealth SciencesMedical ImagingCancer Detection	2005	109
The androgen receptor gene GGN microsatellite and prostate cancer risk. Elizabeth A. Platz, Edward L. Giovannucci, Douglas M. Dahl, PubMed Androgen ReceptorUrologyCancer RiskMedicineGenetics	1998	108

Page 1